Rates of antiretroviral therapy use and viral suppression are reassuringly high among HIV-infected patients who are in care, but many patients remain outside the care system.
Viral suppression is an important goal, not only for individual HIV-infected patients, but also from a public health standpoint as we try to prevent new infections. Estimates suggest that fewer than 30% of people with HIV/AIDS achieve viral suppression, with a somewhat higher rate — 48% to 60% — among patients who are in care. To quantify the levels of antiretroviral therapy (ART) use and viral suppression in the latter group, investigators conducted a cross-sectional study of patients at seven sites in the Centers for AIDS Research Network of Integrated Clinical Systems cohort.
Of 8633 patients with ≥1 medical visit and ≥1 measured viral load in 2010, 94% had ever taken ART, 89% were taking ART, and 70% had viral loads that were “undetectab…
Reviewing Authors
Jonathan Colasanti, MD, MPH
Jonathan Colasanti, MD, MPH
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)